VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer is a research paper published in UNC Libraries (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3U01CA199235-04S1
Identification of synthetic lethal interactors in pancreatic cancer
National Institutes of Health
Grant: 5T32CA009156-20
BASIC MECHANISMS OF VIRAL AND CHEMICAL CARCINOGENESIS
National Institutes of Health
Grant: 5T32GM007040-35
Predoctoral Training in Pharmacological Sciences
National Institutes of Health
Grant: 1T32GM135095-01
Predoctoral Training in the Pharmacological Sciences
National Institutes of Health
Grant: 5T32GM135128-05
NRSA in Genetics
National Institutes of Health
Grant: 5R01ES029079-03
Pathological Reprogramming of DNA Damage Signaling in Neoplastic Cells
National Institutes of Health
Grant: 5R35CA232113-04
Targeting undruggable RAS for cancer treatment
National Institutes of Health
Grant: 5R01CA042978-26
Biological Activity of Ras Oncogenes
National Institutes of Health
Grant: 1F32CA221005-01
Targeting CDK4/6 for pancreatic cancer treatment
National Institutes of Health
Grant: 5R01CA175747-05
Mechanisms of PAK1 activation, signaling and tumor resistance
National Institutes of Health
Grant: 1F32CA239328-01
Defining the roles of ERK MAPK in driving KRAS-mutant pancreatic cancer growth.
National Institutes of Health
Grant: 5P01CA203657-02
Defining RAS isoform- and mutation-specific roles in oncogenesis
National Institutes of Health
Grant: 5R37CA251877-02
Mechanistic dissection and inhibitor targeting of autophagy in RAS driven cancers
National Institutes of Health
Grant: 5F32CA232529-03
Defining the contributions of WT RAS in RAS-mutant lung cancer
National Institutes of Health
Grant: 5R01CA229530-04
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target
Fields of Study
Keywords
Sustainable Development Goals